EP 1039914 A1 20001004 - CYCLOOXYGENASE-2 INHIBITION
Title (en)
CYCLOOXYGENASE-2 INHIBITION
Title (de)
CYCLOOXYGENASE-2 HEMMUNG
Title (fr)
. INHIBITION DE LA CYCLOOXYGENASE-2
Publication
Application
Priority
- US 9825206 W 19981207
- US 6995597 P 19971217
Abstract (en)
[origin: WO9930721A1] Selective inhibitors of cyclooxygenase-2 are used to treat liver disease and in combination with anti-viral drugs to treat virus-caused liver disorders. Selective inhibitors of cyclooxygenase-2 which also inhibit the synthesis of cyclooxygenase-2 improve over the efficacy of conventional selective inhibitors of cyclooxygenase-2 in the treatment of inflammatory conditions, Alzheimer's disease and cancer.
IPC 1-7
IPC 8 full level
A61K 31/365 (2006.01); A61K 31/415 (2006.01); A61K 31/42 (2006.01); A61K 31/655 (2006.01); C07D 231/12 (2006.01); C07D 263/32 (2006.01)
CPC (source: EP)
A61K 31/365 (2013.01); A61K 31/415 (2013.01); A61K 31/421 (2013.01); A61K 31/655 (2013.01); C07D 231/12 (2013.01); C07D 263/32 (2013.01)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9930721 A1 19990624; AU 1703799 A 19990705; CA 2313049 A1 19990624; EP 1039914 A1 20001004; EP 1039914 A4 20070627
DOCDB simple family (application)
US 9825206 W 19981207; AU 1703799 A 19981207; CA 2313049 A 19981207; EP 98961802 A 19981207